Fluorine in PDB 6mvo: Hcv NS5B 1A Y316 Bound to Compound 49

All present enzymatic activity of Hcv NS5B 1A Y316 Bound to Compound 49:
2.7.7.48;

The structure of Hcv NS5B 1A Y316 Bound to Compound 49, PDB code: 6mvo was solved by S.P.Williams, K.Kahler, D.J.Price, A.J.Peat, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	29.28 / 1.95
Space group	P 1
Cell size a, b, c (Å), α, β, γ (°)	53.225, 61.202, 91.773, 89.70, 86.98, 80.92
R / Rfree (%)	21.7 / 23.5

The structure of Hcv NS5B 1A Y316 Bound to Compound 49 also contains other interesting chemical elements:

Chlorine

(Cl)

2 atoms

The binding sites of Fluorine atom in the Hcv NS5B 1A Y316 Bound to Compound 49 (pdb code 6mvo). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Hcv NS5B 1A Y316 Bound to Compound 49, PDB code: 6mvo:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in the Hcv NS5B 1A Y316 Bound to Compound 49


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Hcv NS5B 1A Y316 Bound to Compound 49 within 5.0Å range: probe atom residue distance (Å) B Occ A:F604 b:21.7 occ:1.00 F37 A:K4P604 0.0 21.7 1.0 C36 A:K4P604 1.3 21.3 1.0 C38 A:K4P604 2.4 21.4 1.0 C35 A:K4P604 2.4 21.3 1.0 CG2 A:ILE363 3.1 21.8 1.0 CB A:ILE363 3.2 22.0 1.0 C39 A:K4P604 3.6 21.2 1.0 C34 A:K4P604 3.6 21.2 1.0 O A:HOH735 3.7 15.9 1.0 CD1 A:ILE363 3.9 22.2 1.0 O A:ILE363 3.9 21.7 1.0 CD1 A:LEU360 4.1 23.1 1.0 C33 A:K4P604 4.1 21.2 1.0 CG1 A:ILE363 4.1 22.2 1.0 CG1 A:VAL321 4.2 20.0 1.0 C A:ILE363 4.3 22.1 1.0 CA A:ILE363 4.4 22.1 1.0 O A:LEU360 4.4 22.9 1.0 CD2 A:LEU204 4.5 21.6 1.0 CG2 A:VAL321 4.5 19.6 1.0 CD1 A:LEU204 4.5 21.4 1.0 CB A:VAL321 4.9 19.8 1.0

Fluorine binding site 2 out of 2 in the Hcv NS5B 1A Y316 Bound to Compound 49


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Hcv NS5B 1A Y316 Bound to Compound 49 within 5.0Å range: probe atom residue distance (Å) B Occ B:F605 b:26.2 occ:1.00 F37 B:K4P605 0.0 26.2 1.0 C36 B:K4P605 1.3 25.6 1.0 C35 B:K4P605 2.4 25.7 1.0 C38 B:K4P605 2.4 25.6 1.0 CG2 B:ILE363 3.0 22.3 1.0 CB B:ILE363 3.3 22.3 1.0 C34 B:K4P605 3.6 25.4 1.0 C39 B:K4P605 3.6 25.6 1.0 O B:HOH706 3.8 19.3 1.0 CG1 B:VAL321 3.9 19.0 1.0 O B:ILE363 3.9 22.4 1.0 CD1 B:ILE363 4.0 22.2 1.0 C33 B:K4P605 4.1 25.7 1.0 CG2 B:VAL321 4.2 19.2 1.0 CG1 B:ILE363 4.3 22.3 1.0 CD2 B:LEU204 4.3 20.2 1.0 C B:ILE363 4.3 22.6 1.0 CD1 B:LEU360 4.4 21.1 1.0 CD1 B:LEU204 4.4 19.9 1.0 CA B:ILE363 4.5 22.6 1.0 CB B:VAL321 4.6 18.9 1.0 O B:LEU360 4.8 21.6 1.0 CG B:LEU204 4.9 20.2 1.0

P.Y.Chong, J.B.Shotwell, J.Miller, D.J.Price, A.Maynard, C.Voitenleitner, A.Mathis, S.Williams, J.J.Pouliot, K.Creech, F.Wang, J.Fang, H.Zhang, V.W.Tai, E.Turner, K.M.Kahler, R.Crosby, A.J.Peat. Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired By Metabolites of A Failed Clinical Hcv Inhibitor. J.Med.Chem. V. 62 3254 2019.
ISSN: ISSN 0022-2623
PubMed: 30763090
DOI: 10.1021/ACS.JMEDCHEM.8B01719